Skip to main content
. 2012 Nov 7;7(11):e48184. doi: 10.1371/journal.pone.0048184

Figure 2. Kaplan-Meier survival curves for all nonischemic patients and according to Latent Class Model B subtype, bucindolol vs. placebo.

Figure 2